6-K 1 dp50156_6k.htm FORM 6-K
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 6-K
 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 
For the month of October, 2014
Commission File Number: 001-13742

ISRAEL CHEMICALS LTD.
(Exact name of registrant as specified in its charter)

Israel Chemicals Ltd.
Millennium Tower
23 Aranha Street
P.O. Box 20245
Tel Aviv, 61202 Israel
(972-3) 684-4400
(Address of principal executive office)

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

Form 20-F
   X  
 
Form 40-F
 ____

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

Yes
 ____  
No
   X  

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

Yes
 ____  
No
   X  



 
 
 
 
 
ISRAEL CHEMICALS LTD.
 
This report on Form 6-K is being furnished to provide the following information that was filed in Israel by Israel Chemicals Ltd. pursuant to Israeli Securities Law requirements.  This report is being furnished and not filed.
 
1.
Israel Corporation Ltd.’s announcement dated October 12, 2014 regarding the Exercise of Options by the Underwriters.
 
 
 
 
 
Item 1


This is an English convenience translation of the original Hebrew version. In case of any discrepancy, the binding version is the Hebrew original.
 



 
  Israel Corporation Ltd.  
    Form 121
  Registrar Number: 520028010 Public
     
 
Securities of the Corporation are listed in the Tel Aviv Stock Exchange
 
Sort name: Israel Corporation
 
Address: P.O.B. 20456, Tel Aviv 61204
 
Tel: 03-6844517, 6844500, Fax: 03-6844587
 
Email: MAYAAK@ISRAELCORP.COM
  
 
 
Date of Transmission: October 12, 2014
 
Reference: 2014-01-174588
 
To:
 
The Securities Authority
To:
 
The Tel Aviv Stock Exchange
  
     
www.isa.gov.il
www.tase.co.il
  

 
Immediate Report
 
The Event: Exercise of options by the underwriters

See the attached report.

The date when the event first became known to the corporation: October 7, 2014
Time: 19:00

The name of the authorized signatory to the report and the name of the authorized electronic signatory: Maya Alcheh-Kaplan
Position: Vice President, General Counsel and Company Secretary
Signing date: October 12, 2014

 
 
 
 
Israel Corporation Ltd.
Millennium Tower, 23 Aranha St., P.O.B. 20456, Tel Aviv 61204
Tel: (03) 6844517, Fax: (03) 36844587
 
Attorney Maya Alcheh-Kaplan
Vice President
General Counsel and Company Secretary
 
 

ISRAEL CORPORATION
October 12, 2014

TO:
  
THE SECURITIES AUTHORITY
THE TEL AVIV STOCK EXCHANGE LTD.
www.isa.gov.il
www.tase.co.il

 
Re: Immediate Report – Exercise of options by the underwriters
 
Pursuant to the Company's report dated September 24, 2014 (reference No.: 2014-01-164040) regarding the Company's entry into transactions in connection with ICL shares, the Company hereby wish to update that the American underwriters with whom the Company engaged in an underwriting agreement as mentioned in the aforesaid report, has exercised the option granted to them in the underwriting agreement to purchase 6,015,814 ordinary shares of ICL at the price of the public offering. After the exercise of the option the Company is expected to hold 49.02% of the issued share capital of ICL and 46.18% in voting rights.

 
Sincerely,
 
Israel Corporation Ltd.
 

 
The name of the authorized signatory to the report and the name of the authorized electronic signatory: Maya Alcheh-Kaplan.
Position: Vice President, General Counsel & Company Secretary.
Date of signature: October 12, 2014.
 
 
 
 

SIGNATURE


Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
 

   
Israel Chemicals Ltd.
     
     
By:
/s/ Avi Doitchman
       
Name:
Avi Doitchman
       
Title:
Executive Vice Persident, Chief Financial Officer & Strategy, Manager of Market Risk Management

   
Israel Chemicals Ltd.
     
     
By:
/s/ Lisa Haimovitz
       
Name:
Lisa Haimovitz
       
Title:
Vice President, General Counsel and Corporate Secretary

Date: October 14, 2014